Mesoblast | MSB - Ebit


Mesoblast reported $-27.75M in EBIT for its fiscal semester ending in December of 2025.





Ebit Change Date
Avita Medical AUD -10.39M 1.72M Dec/2025
Clinuvel Pharmaceuticals AUD 13.51M 15.95M Dec/2025
Cochlear AUD 261.1M 13.9M Dec/2025
CSL USD 2.64B 116M Dec/2025
Pacific Edge NZD -19.4M 2.91M Dec/2025
Paradigm Biopharmaceuticals AUD -21.57M 11.26M Dec/2025
PYC Therapeutics AUD -22.59M 3.25M Dec/2025
Ramsay Health Care AUD 541.1M 20.7M Dec/2025
Sonic Healthcare AUD 423.94M 80.3M Dec/2024
Starpharma Holdings AUD -873K 161K Dec/2025
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025